In PCI-treated STEMI, LAD culprit territory and admission systolic blood pressure were the main clinical correlates of early post-PCI LV dysfunction, whereas TG/HDL-C showed only modest discrimination and limited standalone clinical utility.
Abstract
INTRODUCTION
Early left ventricular systolic dysfunction after primary percutaneous coronary intervention (PCI) remains common in ST-segment elevation myocardial infarction (STEMI) and is associated with adverse remodeling and heart failure. The clinical relevance of lipid markers and lipid ratios for characterizing early post-PCI ventricular dysfunction beyond angiographic and hemodynamic features remains uncertain.
Methods
We conducted a single-center retrospective study of consecutive patients with STEMI undergoing emergency PCI at Nanjing BenQ Hospital (2014-2023). LVEF was assessed by transthoracic echocardiography 24-72 h post-PCI, and reduced LVEF was defined as < 50%. Lipids were measured from the first blood sample obtained on admission, and LDL-C/HDL-C and TG/HDL-C were calculated. Multivariable linear and logistic regression models with hierarchical adjustment (Model 2 additionally including log1p-transformed troponin I measured from the first blood sample obtained on admission) were used to identify factors associated with LVEF and reduced LVEF. Discrimination of lipid markers was evaluated using ROC analysis.
Results
Among 254 patients, 45 (17.7%) had reduced LVEF. LAD as the infarct-related artery (IRA) was more frequent in the reduced-LVEF group (73.3% vs. 48.3%, P = 0.002). LAD-IRA was independently associated with lower LVEF (β = -5.240; P < 0.001) and higher odds of reduced LVEF (OR = 4.005; P < 0.001). Higher systolic blood pressure was associated with lower odds of reduced LVEF (P = 0.026). TG/HDL-C showed modest discrimination (AUC = 0.605), whereas LDL-C showed no meaningful discrimination (AUC = 0.492).
Conclusion
In PCI-treated STEMI, LAD culprit territory and admission systolic blood pressure were the main clinical correlates of early post-PCI LV dysfunction, whereas TG/HDL-C showed only modest discrimination and limited standalone clinical utility. These findings should be considered exploratory and hypothesis-generating.
Left ventricular ejection fraction (LVEF) is the standard marker for systolic function, but it fails to detect subtle changes in myocardial contractility in patients after an ST-elevation myocardial infarction (STEMI). Thus, a new way to evaluate left ventricular (LV) function with high precision is needed to assess di...
Gomaa Abdelrazek, Mahmoud H. Mahmoud, Gousay A. Alkhazmari et al.· Journal of Cardiovascular Im...· 0 citations
Background: Percutaneous coronary intervention (PCI) is a key revascularization strategy for coronary artery disease, but some patients still experience major adverse cardiovascular events (MACE) post-procedure. Myocardial injury biomarkers reflect cardiomyocyte damage, yet evidence on their combined analysis for post-...
Yiqun Lou, Liuping Wang, Hai-Ying Li et al.· Discover medicine· 0 citations
We aimed to investigate association of three DanGer Shock trial criteria [systolic blood pressure [SBP] < 100 mmHg, lactate ≥ 2.5 mmol/L, and left ventricular ejection fraction (LVEF) < 45%] on clinical outcomes among patients with ST-elevation myocardial infarction (STEMI) in Japan and evaluate whether these criteria...
Narumi Irie, Y. Sawayama, Mikitaka Fujita et al.· Heart and Vessels· 0 citations
Background/Objectives: Age may influence myocardial recovery after acute myocardial infarction (AMI) beyond changes in left ventricular ejection fraction (LVEF). We investigated age-related patterns in ischemic delay, admission biomarkers, biventricular function, myocardial deformation, and exploratory patterns of pres...
Bogdan-Sorin Tudurachi, L. Anghel, Andreea Tudurachi et al.· Biomedicines· 0 citations
Background: Heart failure with reduced ejection fraction (HFrEF) may be caused by various factors. The etiology of HFrEF may influence prognosis and further management. Objectives: In this study we aimed to assess differences between ischemic and non-ischemic etiology in the context of clinical features, hemodynamic ev...
M. Dąbrowska, M. Potapowicz-Krysztofiak, M. Kiliszek et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.